12/06/2018
di Fidia Farmaceutica Spa
Sooft is active in the treatment of all major eye conditions through Sooft, Bioos, Glaucoom, OftaH.T. e Neoox trademarks
The company owns 27 patents, further bolstering Fidia Pharma Group’s already strong portfolio, consisting of more than 900 patents, of which over 650 on hyaluronic acid
Abano Terme (PD), June 11, 2018 – Fidia Pharma Group, an Italian multinational company, leader in…
25/04/2018
di Fidia Farmaceutica Spa
Potential beneficial effect of HYMOVIS® on pain and function
Structural modifying effect in knee OA with HYMOVIS®
Abano Terme, Italy, April 25, 2018 – Fidia Farmaceutici, a world leader in the research, development…
19/03/2018
di Fidia Farmaceutica Spa
No new drug treatments for primary or recurrent papillary bladder cancer in 15 years
Oncofid®P-B is a Paclitaxel-Hyaluronan Bioconjugate developed and patented by Fidia farmaceutici, a leading Italian pharmaceutical multinational company
Copenhagen, March 18, 2018 – Fidia farmaceutici today announced the positive results from a phase II…